CY1121053T1 - Ενα γονιδιο που κωδικοποιει ενα ομολογο ανθρωπινης ρ-γλυκοπρωτεϊνης με ανθεκτικοτητα απεναντι σε πολλαπλα φαρμακα πανω στο χρωμοσωμα 7p15-21 και χρησεις αυτου - Google Patents

Ενα γονιδιο που κωδικοποιει ενα ομολογο ανθρωπινης ρ-γλυκοπρωτεϊνης με ανθεκτικοτητα απεναντι σε πολλαπλα φαρμακα πανω στο χρωμοσωμα 7p15-21 και χρησεις αυτου

Info

Publication number
CY1121053T1
CY1121053T1 CY181100185T CY181100185T CY1121053T1 CY 1121053 T1 CY1121053 T1 CY 1121053T1 CY 181100185 T CY181100185 T CY 181100185T CY 181100185 T CY181100185 T CY 181100185T CY 1121053 T1 CY1121053 T1 CY 1121053T1
Authority
CY
Cyprus
Prior art keywords
glycoprotein
gene
multiple drugs
human
codes
Prior art date
Application number
CY181100185T
Other languages
English (en)
Inventor
Mohamed H Sayegh
Markus H Frank
Original Assignee
The Brigham And Women´S Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Brigham And Women´S Hospital Inc filed Critical The Brigham And Women´S Hospital Inc
Publication of CY1121053T1 publication Critical patent/CY1121053T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Η εφεύρεση σχετίζεται με μία Ρ-γλυκοπρωτεΐνη της οικογένειας MDR που βρίσκεται πάνω στο ανθρώπινο χρωμόσωμα, με αλληλουχίες πολυνουκλεοτιδίου, που κωδικοποιούν αυτήν την Ρ-γλυκοπρωτεΐνη και θραύσματα αυτής. Αυτό το γονίδιο χρησιμοποιείται σε μεθόδους για τον προσδιορισμό της ευαισθησίας των καρκινικών κυττάρων σε θεραπείες που κατευθύνονται έναντι της ανθεκτικότητας σε πολλαπλά φάρμακα, και στον σχεδιασμό διαγνωστικών και θεραπευτικών μεθόδων, που σχετίζονται με την ανθεκτικότητα απέναντι σε πολλαπλά φάρμακα για τον καρκίνο. Αυτή η εφεύρεση σχετίζεται επίσης με μεθόδους για τον προσδιορισμό του κατά πόσον μία δοκιμαστική ένωση μπορεί να αναστείλει την ανθεκτικότητα σε πολλαπλά φάρμακα.
CY181100185T 2000-06-05 2018-02-14 Ενα γονιδιο που κωδικοποιει ενα ομολογο ανθρωπινης ρ-γλυκοπρωτεϊνης με ανθεκτικοτητα απεναντι σε πολλαπλα φαρμακα πανω στο χρωμοσωμα 7p15-21 και χρησεις αυτου CY1121053T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20891300P 2000-06-05 2000-06-05
EP01941884A EP1290028B1 (en) 2000-06-05 2001-06-05 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF
EP09180026.8A EP2182005B1 (en) 2000-06-05 2001-06-05 A gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof

Publications (1)

Publication Number Publication Date
CY1121053T1 true CY1121053T1 (el) 2019-12-11

Family

ID=22776565

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20101100281T CY1109941T1 (el) 2000-06-05 2010-03-23 ΕΝΑ ΓΟΝΙΔΙΟ ΠΟΥ ΚΩΔΙΚΟΠΟΙΕΙ ΕΝΑ ΟΜΟΛΟΓΟ ΑΝΘΡΩΠΙΝΗΣ Ρ-ΓΛΥΚΟΠΡΩΤΕΙΝΗΣ ΜΕ ΑΝΘΕΚΤΙΚΟΤΗΤΑ ΑΠΕΝΑΝΤΙ ΣΕ ΠΟΛΛΑ ΦΑΡΜΑΚΑ ΠΑΝΩ ΣΤΟ ΧΡΩΜΟΣΩΜΑ 7p15-21 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΟΥ
CY181100185T CY1121053T1 (el) 2000-06-05 2018-02-14 Ενα γονιδιο που κωδικοποιει ενα ομολογο ανθρωπινης ρ-γλυκοπρωτεϊνης με ανθεκτικοτητα απεναντι σε πολλαπλα φαρμακα πανω στο χρωμοσωμα 7p15-21 και χρησεις αυτου

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20101100281T CY1109941T1 (el) 2000-06-05 2010-03-23 ΕΝΑ ΓΟΝΙΔΙΟ ΠΟΥ ΚΩΔΙΚΟΠΟΙΕΙ ΕΝΑ ΟΜΟΛΟΓΟ ΑΝΘΡΩΠΙΝΗΣ Ρ-ΓΛΥΚΟΠΡΩΤΕΙΝΗΣ ΜΕ ΑΝΘΕΚΤΙΚΟΤΗΤΑ ΑΠΕΝΑΝΤΙ ΣΕ ΠΟΛΛΑ ΦΑΡΜΑΚΑ ΠΑΝΩ ΣΤΟ ΧΡΩΜΟΣΩΜΑ 7p15-21 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΟΥ

Country Status (11)

Country Link
US (6) US6846883B2 (el)
EP (5) EP3333182A1 (el)
AT (1) ATE452909T1 (el)
CA (1) CA2411101C (el)
CY (2) CY1109941T1 (el)
DE (1) DE60140868D1 (el)
DK (4) DK2182005T3 (el)
ES (4) ES2659877T3 (el)
HK (2) HK1143823A1 (el)
PT (4) PT1290028E (el)
WO (1) WO2001094400A2 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1290028E (pt) 2000-06-05 2010-03-12 Brigham & Womens Hospital Um gene que codifica um homólogo de glicoproteína p humana de resistência a múltiplos fármacos, situado no cromossoma 7p15-21 e suas utilizações
WO2003025174A2 (en) * 2001-09-06 2003-03-27 Bayer Healthcare Ag Regulation of human mrp1-like protein
LT2772535T (lt) 2006-05-31 2022-08-25 Children's Medical Center Corporation Abc5 atžvilgiu teigiamos mezenchiminės kamieninės ląstelės kaip imunomoduliatoriai
ES2687270T3 (es) 2007-04-12 2018-10-24 The Brigham And Women's Hospital, Inc. Fijación como objetivo de ABCB5 para la terapia del cáncer
US11542328B2 (en) 2008-11-14 2023-01-03 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
CA2743464A1 (en) 2008-11-14 2010-05-20 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
EP3865573A1 (en) 2013-02-19 2021-08-18 Children's Medical Center Corporation Abcb5(+) stem cells for treating ocular disease
WO2014182994A1 (en) 2013-05-10 2014-11-13 Children's Medical Center Corporation Wound healing and tissue engineering
US11382931B2 (en) * 2016-07-14 2022-07-12 University Of Southern California Methods and composition for producing and using immune cells and stem cells for cell-based therapies
KR20230034944A (ko) * 2020-04-30 2023-03-10 칠드런'즈 메디컬 센터 코포레이션 Abcb5에 특이적인 항체 및 그의 용도

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0174810B1 (en) * 1984-09-10 1993-07-21 HSC Research Development Corporation Multidrug resistance in mammalian cell lines and isolation of determinant glycoprotein dna
US4837306A (en) 1985-02-25 1989-06-06 The Ontario Cancer Institute Method for selecting hybridomas producing antibodies specific to the P-glycoprotein cell suface antigen and a cDNA clone encoding the C-terminal portion of the antigen
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5399483A (en) * 1989-03-30 1995-03-21 Suntory Limited Expression of MDR-related gene in yeast cell
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US5434075A (en) * 1992-03-20 1995-07-18 Board Of Trustees Of The University Of Illinois Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
IT1257893B (it) * 1992-06-17 1996-02-16 Ist Superiore Sanita Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteina umana.
WO1994009363A1 (en) * 1992-10-14 1994-04-28 Board Of Regents, The University Of Texas System Cancer diagnosis and therapy
AU719392B2 (en) 1996-10-01 2000-05-11 Kyowa Hakko Kirin Co., Ltd. Nitrogen-containing heterocyclic compounds
US6020191A (en) 1997-04-14 2000-02-01 Genzyme Corporation Adenoviral vectors capable of facilitating increased persistence of transgene expression
US6008002A (en) * 1997-09-29 1999-12-28 Bodey; Bela Immunomagnetic detection and isolation of cancer cells
SI1659178T1 (sl) * 1998-02-05 2010-07-30 Glaxosmithkline Biolog Sa Postopek za čiščenje ali proizvodnjo MAGE proteina
WO1999046366A1 (en) 1998-03-13 1999-09-16 Osiris Therapeutics, Inc. Uses for humane non-autologous mesenchymal stem cells
CA2384981A1 (en) * 1999-09-28 2001-04-05 Gentest Corporation P-glycoproteins and uses thereof
WO2001057252A2 (en) * 2000-02-04 2001-08-09 Aeomica, Inc. Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes
PT1290028E (pt) 2000-06-05 2010-03-12 Brigham & Womens Hospital Um gene que codifica um homólogo de glicoproteína p humana de resistência a múltiplos fármacos, situado no cromossoma 7p15-21 e suas utilizações
JP2004500873A (ja) 2000-06-22 2004-01-15 ジェネンテック・インコーポレーテッド アゴニスト抗−ｔｒｋ−ｃモノクローナル抗体
AU2002241569A1 (en) * 2000-10-27 2002-05-27 Incyte Genomics, Inc. Transporters and ion channels
JP2007512017A (ja) * 2003-11-24 2007-05-17 ザ ロックフェラー ユニバーシティー 自己複製多能性遅延周期細胞を単離する方法
US20050186672A1 (en) 2004-01-27 2005-08-25 Reliance Life Sciences Pvt. Ltd. Tissue system with undifferentiated stem cells derived from corneal limbus
US10538742B2 (en) 2004-11-12 2020-01-21 Cambridge Enterprise Limited Methods and means related to cancer stem cells
WO2006103685A2 (en) 2005-03-28 2006-10-05 Vision Research Foundation A method for cultivating cells derived from corneal limbal tissue and cells deived from corneal limbal tissue
CA2612021A1 (en) 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
LT2772535T (lt) * 2006-05-31 2022-08-25 Children's Medical Center Corporation Abc5 atžvilgiu teigiamos mezenchiminės kamieninės ląstelės kaip imunomoduliatoriai
US20080118432A1 (en) * 2006-09-07 2008-05-22 Ivan Bergstein Monitoring cancer stem cells
ES2687270T3 (es) 2007-04-12 2018-10-24 The Brigham And Women's Hospital, Inc. Fijación como objetivo de ABCB5 para la terapia del cáncer
CA2743464A1 (en) 2008-11-14 2010-05-20 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
EP3865573A1 (en) 2013-02-19 2021-08-18 Children's Medical Center Corporation Abcb5(+) stem cells for treating ocular disease
WO2014182994A1 (en) 2013-05-10 2014-11-13 Children's Medical Center Corporation Wound healing and tissue engineering

Also Published As

Publication number Publication date
US20090162873A1 (en) 2009-06-25
CA2411101A1 (en) 2001-12-13
PT1290028E (pt) 2010-03-12
EP3333182A1 (en) 2018-06-13
DK2230253T3 (da) 2013-11-18
CA2411101C (en) 2018-01-16
ATE452909T1 (de) 2010-01-15
US8076091B2 (en) 2011-12-13
HK1257165A1 (zh) 2019-10-18
DK2182005T3 (en) 2015-06-29
HK1143823A1 (en) 2011-01-14
DK2298799T3 (en) 2018-02-19
WO2001094400A3 (en) 2002-07-04
PT2230253E (pt) 2013-11-11
WO2001094400A2 (en) 2001-12-13
EP2182005B1 (en) 2015-03-25
EP2298799B1 (en) 2017-11-15
US20120034196A1 (en) 2012-02-09
ES2540102T3 (es) 2015-07-08
ES2659877T3 (es) 2018-03-19
US7465554B2 (en) 2008-12-16
US20050049185A1 (en) 2005-03-03
EP2230253B1 (en) 2013-08-07
US20020037522A1 (en) 2002-03-28
EP2298799A1 (en) 2011-03-23
PT2182005E (pt) 2015-07-20
US8425876B2 (en) 2013-04-23
PT2298799T (pt) 2018-02-16
EP1290028B1 (en) 2009-12-23
DK1290028T3 (da) 2010-04-26
ES2338756T3 (es) 2010-05-12
ES2434721T3 (es) 2013-12-17
CY1109941T1 (el) 2014-09-10
EP2182005A1 (en) 2010-05-05
DE60140868D1 (de) 2010-02-04
US9561264B2 (en) 2017-02-07
US6846883B2 (en) 2005-01-25
EP1290028A2 (en) 2003-03-12
US20130287785A1 (en) 2013-10-31
EP2230253A1 (en) 2010-09-22
US20100145030A1 (en) 2010-06-10
US8507273B2 (en) 2013-08-13

Similar Documents

Publication Publication Date Title
CY1121053T1 (el) Ενα γονιδιο που κωδικοποιει ενα ομολογο ανθρωπινης ρ-γλυκοπρωτεϊνης με ανθεκτικοτητα απεναντι σε πολλαπλα φαρμακα πανω στο χρωμοσωμα 7p15-21 και χρησεις αυτου
Spenlé et al. Tenascin-C: Exploitation and collateral damage in cancer management
Zhou et al. Increased methylation of the MOR gene proximal promoter in primary sensory neurons plays a crucial role in the decreased analgesic effect of opioids in neuropathic pain
ATE353974T1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
CY1111147T1 (el) Διαμεμβρανικο αντιγονο λεκτινης τυπου c εκφραζομενο σε καρκινο στον προστατη ανθρωπου και χρησεις αυτου
MXPA02000192A (es) Composiciones y metodos para la terapia y diagnostico de cancer de pulmon.
WO2001096388A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
CO4600637A1 (es) Compuestos para inmunoterapia e inmunodiagnosis del cancer de prostata
CY1110029T1 (el) Γονιδιο που εκφραζεται στον καρκινο του προστατη
WO2004000094A8 (en) Predictive markers in cancer therapy
Koh et al. Brain somatic mutations in epileptic disorders
EP1767636A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
CY1105380T1 (el) Προτιμωμενα τμηματα της νευρικης νηματικης πρωτεϊνης και μεθοδοι χρησης αυτων
NO20052956L (no) Defensinprotiner
HUP0301812A2 (hu) Átvizsgálási (screening) eljárás
CY1105566T1 (el) Ποσοτικη διαγνωστικη αναλυση της προδιαθεσης για υπερταση
DK1536006T3 (da) Cancerantigener og anvendelse deraf
CY1109029T1 (el) Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη ονομαζομενη 85p1b3 χρησιμα στην αγωγη και τον εντοπισμο του καρκινου
WO2001051513A3 (en) Ovarian tumor-associated sequences
WO2004070012A3 (en) Cell-killing molecules and methods of use thereof
CY1114585T1 (el) ΑΝΤΙΣΩΜΑΤΑ ΚΑΤΑ ΕΝΟΣ ΟΜΟΛΟΓΟΥ ΤΗΣ MDR p-ΓΛΥΚΟΠΡΩΤΕΪΝΗΣ ΕΠΑΝΩ ΣΤΟ ΧΡΩΜΟΣΩΜΑ 7p15-21 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
ATE527370T1 (de) Sparc-promotormutationen im zusammenhang mit arzneistoffresistenz sowie damit verbundene verfahren
EA200001127A1 (ru) Бактериальные феромоны и их использование
DE60319342D1 (de) N rheumatoider arthritis
WO2001096389A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer